Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate (21)
- Information Technology Services Directorate (2)
- Isotope Science and Enrichment Directorate (6)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
Researcher
- Sergiy Kalnaus
- Alexander I Kolesnikov
- Alexei P Sokolov
- Bekki Mills
- Beth L Armstrong
- Bruce Moyer
- Debjani Pal
- Georgios Polyzos
- Jaswinder Sharma
- Jeffrey Einkauf
- Jennifer M Pyles
- John Wenzel
- Justin Griswold
- Keju An
- Kuntal De
- Laetitia H Delmau
- Luke Sadergaski
- Mark Loguillo
- Matthew B Stone
- Mike Zach
- Nancy Dudney
- Padhraic L Mulligan
- Sandra Davern
- Shannon M Mahurin
- Tao Hong
- Tomonori Saito
- Victor Fanelli

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

We developed and incorporated two innovative mPET/Cu and mPET/Al foils as current collectors in LIBs to enhance cell energy density under XFC conditions.

Neutron scattering experiments cover a large temperature range in which experimenters want to test their samples.

Neutron beams are used around the world to study materials for various purposes.

The co-processing of cathode and composite electrolyte for solid state polymer batteries has been developed. A traditional uncalendared cathode of e.g.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

An ORNL team has developed a method for screening for an immunoregulatory protein, which includes assessing the sequence of a candidate protein to determine if it is an immunoregulatory protein when at least one plasminogen-apple-nematode (PAN) domain with a consensus sequence